Rolf Ehrnström

Born 1953. Member of the Board of Directors since 2020.

Independent of the Company and independent of major shareholders.

Education and experience: Royal Institute of Technology; M.Sc. in Biochemistry & Biotechnology. Extensive experience from Life Science Industry. Scientific and Product Development management roles in LKB/Pharmacia Biotech/Amersham-Pharmacia Biotech. Co-founder and VP R&D of Gyros AB, CVP/CSO of Dako-Agilent A/S, Boardmember of Biomonitor A/S.

Current assignments: CSO of Immunovia AB, Boardmember of Gradientech AB, Boardmember of Fluimedix A/S,  CEO and owner of Reomics AB, Partner in Ventac Partners, Partner in Ventac Capital

Previous assignments (last five years): –

Rolf Ehrnström holds 72,617 B-shares direct or via company.